Increased Serum Nitric Oxide Concentration After Bariatric Surgery—A Potential Mechanism for Cardiovascular Benefit
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
It is believed that endothelial dysfunction associated with obesity contributes to reduced vascular production of nitric oxide (NO). Weight reduction after bariatric surgery is known to decrease the risk of cardiovascular disease. The purpose of this study was to determine whether bariatric surgery leads to improvement of metabolic markers of endothelial function: serum NO and its precursor (arginine) concentrations in obese patients.
Serum NO and l-arginine concentrations were measured in 25 morbidly obese patients directly before and 6 months after bariatric surgery. Moreover, selected parameters that may be involved in development of endothelial dysfunction were also studied. Control group consisted of ten healthy individuals with normal body weight.
Six months after bariatric surgery, serum NO concentration was approximately 40% higher than before surgery. Surprisingly, serum NO concentration in nonobese controls was essentially similar to obese patients before surgery. In contrast, serum l-arginine concentration was higher in obese patients than in controls and decreased significantly after surgery. The body weight, blood pressure, triacylglycerols, LDL/HDL-cholesterol ratio, insulin, homeostasis model assessment score (HOMA-index), C-reactive protein, and white blood cell count were higher in obese patients as compared with controls and decreased significantly after surgery.
Our results indicate that improvement of insulin resistance, lipidemia, and blood pressure as well as reduction of systemic inflammation after bariatric surgery were associated with the increase of serum NO concentration. We propose that the increase in serum NO concentration contribute to diverse beneficial effects of weight loss after bariatric surgery especially in the context of risk of atherosclerosis.
- Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol. 2008;158:135–45. CrossRef
- Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–26. CrossRef
- Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103:398–406. CrossRef
- Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet. 2001;358:1400–4. CrossRef
- Raitakari M, Ilvonen T, Ahotupa M, et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol. 2004;24:124–8. CrossRef
- Higashi Y, Sasaki S, Nakagawa K, et al. Low body mass index is a risk factor for impaired endothelium-dependent vasodilation in humans: role of nitric oxide and oxidative stress. J Am Coll Cardiol. 2003;42:256–63. CrossRef
- Williams IL, Chowienczyk PJ, Wheatcroft SB, et al. Endothelial function and weight loss in obese humans. Obes Surg. 2005;15:1055–60. CrossRef
- Fenster CP, Darley-Usmar VM, Landar AL, et al. Weight loss and race modulate nitric oxide metabolism in overweight women. Free Radic Biol Med. 2004;37:695–702. CrossRef
- Miyaki A, Maeda S, Yoshizawa M, et al. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men. Angiology. 2009;60:351–7. CrossRef
- Maniscalco M, de Laurentiis G, Zedda A, et al. Exhaled nitric oxide in severe obesity: effect of weight loss. Respir Physiol Neurobiol. 2007;156:370–3. CrossRef
- Lin LY, Lee WJ, Shen HN, et al. Nitric oxide production is paradoxically decreased after weight reduction surgery in morbid obesity patients. Atherosclerosis. 2007;190:436–42. CrossRef
- Chen PY, Sanders PW. l-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559–67. CrossRef
- Gokce N. l-arginine and hypertension. J Nutr. 2004;134:2807S–11.
- Wu G, Bazer FW, Davis TA, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153–68. CrossRef
- Sledzinski T, Goyke E, Smolenski RT, et al. Decrease in serum protein carbonyl groups concentration and maintained hyperhomocysteinemia in patients undergoing bariatric surgery. Obes Surg. 2009;19:321–6. CrossRef
- Swierczynski J, Sledzinski T, Slominska E, et al. Serum phenylalanine concentration as a marker of liver function in obese patients before and after bariatric surgery. Obes Surg. 2009;19:883–9. CrossRef
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
- Zabrocka L, Raczynska S, Goyke E, et al. BMI is the main determinant of the circulating leptin in women after vertical banded gastroplasty. Obes Res. 2004;12:505–12. CrossRef
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. CrossRef
- Ashrafian H, le Roux CW, Darzi A, et al. Effects of bariatric surgery on cardiovascular function. Circulation. 2008;118:2091–102. CrossRef
- Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation. 2002;106:2530–2. CrossRef
- Fernandez ML, Webb D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr. 2008;27:1–5.
- Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest. 1997;100:2417–23. CrossRef
- Drew BG, Fidge NH, Gallon-Beaumier G, et al. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci U S A. 2004;101:6999–7004. CrossRef
- Uittenbogaard A, Shaul PW, Yuhanna IS, et al. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem. 2000;275:11278–83. CrossRef
- de Carvalho CP, Marin DM, de Souza AL, et al. GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism. Obes Surg. 2009;19:313–20. CrossRef
- de la Garcia T, Rubio MA, Bordiu E, et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab. 2008;93:4276–81. CrossRef
- Simon I, Escote X, Vilarrasa N, et al. Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Obesity (Silver Spring). 2009;17:1124–8.
- Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 2009;6:27–35. CrossRef
- Ritchie SA, Ewart MA, Perry CG, et al. The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci (Lond). 2004;107:519–32. CrossRef
- Konukoglu D, Uzun H, Firtina S, et al. Plasma adhesion and inflammation markers: asymmetrical dimethyl-l-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg. 2007;17:672–8. CrossRef
- Krzyzanowska K, Mittermayer F, Kopp HP, et al. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab. 2004;89:6277–81. CrossRef
- Noronha BT, Li JM, Wheatcroft SB, et al. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes. 2005;54:1082–9. CrossRef
- Jobgen WS, Fried SK, Fu WJ, et al. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17:571–88. CrossRef
- Loscalzo J. What we know and don't know about l-arginine and NO. Circulation. 2000;101:2126–9.
- Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J, et al. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity. Metabolism. 2004;53:1268–73. CrossRef
- Gruber HJ, Mayer C, Mangge H, et al. Obesity reduces the bioavailability of nitric oxide in juveniles. Int J Obes (Lond). 2008;32:826–31. CrossRef
- Konukoglu D, Serin O, Turhan MS. Plasma leptin and its relationship with lipid peroxidation and nitric oxide in obese female patients with or without hypertension. Arch Med Res. 2006;37:602–6. CrossRef
- Increased Serum Nitric Oxide Concentration After Bariatric Surgery—A Potential Mechanism for Cardiovascular Benefit
Volume 20, Issue 2 , pp 204-210
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Nitric oxide (NO)
- Bariatric surgery
- Industry Sectors
- Author Affiliations
- 1. Department of Pharmaceutical Biochemistry, Medical University of Gdansk, Gdansk, Poland
- 2. Department of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Gdansk, Poland
- 3. Department of Biochemistry, Medical University of Gdansk, Debinki 1, 80-211, Gdansk, Poland